Clearmind Medicine (STU:CWY0) OCF Margin %: 0.00% (As of Apr. 2026)


STU:CWY0 Clearmind Medicine Inc STU:CWY0
22 GF Score
Price €26.00
! 1 Warning Sign
View Full Analysis

What is Clearmind Medicine OCF Margin %?

Clearmind Medicine STU:CWY0 22 OCF Margin % is 0.00% as of Apr. 2026. GuruFocus rates STU:CWY0 with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Clearmind Medicine ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Clearmind Medicine's Cash Flow from Operations for the three months ended in Apr. 2026 was €-1.51 Mil. Clearmind Medicine's Revenue for the three months ended in Apr. 2026 was €0.00 Mil. Therefore, Clearmind Medicine's OCF Margin % for the quarter that ended in Apr. 2026 was 0.00%.

As of today, Clearmind Medicine's current OCF Yield % is -173.85%.

The historical rank and industry rank for Clearmind Medicine's OCF Margin % or its related term are showing as below:


STU:CWY0's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Clearmind Medicine OCF Margin % Related Terms

Clearmind Medicine OCF Margin % Historical Data

* Premium members only.

The historical data trend for Clearmind Medicine's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clearmind Medicine OCF Margin % Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Clearmind Medicine Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:CWY0
22GF Score
Clearmind Medicine Inc STU:CWY0
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clearmind Medicine OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Clearmind Medicine's OCF Margin for the fiscal year that ended in Oct. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-4.067/0
= %

Clearmind Medicine's OCF Margin for the quarter that ended in Apr. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-1.512/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Clearmind Medicine (STU:CWY0) has a OCF Margin % of 0.00% as of Apr. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Clearmind Medicine and its competitors. According to the industry distribution chart, Clearmind Medicine ranks #999999 out of 959 companies in the Biotechnology industry.
Is Clearmind Medicine's OCF Margin % too high?
Clearmind Medicine's current OCF Margin % is 0.00%. Based on the distribution chart, Clearmind Medicine ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Clearmind Medicine has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Clearmind Medicine's OCF Margin % compare to BIXT and GRI?
According to the Biotechnology industry distribution chart, Clearmind Medicine ranks #999999 out of 959 companies for OCF Margin %. This places Clearmind Medicine in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Clearmind Medicine and its competitors. Clearmind Medicine's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clearmind Medicine stock overvalued right now?
Clearmind Medicine (STU:CWY0) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Clearmind Medicine's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Clearmind Medicine (STU:CWY0), the current OCF Margin % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clearmind Medicine Business Description

Other Exchanges CMND:USA
Address 101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H1A5
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
22GF Score

Get the complete analysis for STU:CWY0

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.00
Price